Quarterly report · Q1

Period2022-07-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥5.4bn2022-07-01 → 2022-09-30Cons.Net sales
Revenue¥20.4bn2021-07-01 → 2022-06-30Cons.Net sales (5-year summary)
Revenue¥4.8bn2021-07-01 → 2021-09-30Cons.Net sales
Operating income¥1.0bn2022-07-01 → 2022-09-30Cons.Operating income
Operating income¥871m2021-07-01 → 2021-09-30Cons.Operating income
Ordinary income¥979m2022-07-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥3.8bn2021-07-01 → 2022-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥876m2021-07-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥979m2022-07-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥876m2021-07-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥606m2022-07-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.4bn2021-07-01 → 2022-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥606m2021-07-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥606m2022-07-01 → 2022-09-30Cons.Profit loss
Net income¥606m2021-07-01 → 2021-09-30Cons.Profit loss
Total assets¥26.3bnat 2022-09-30Cons.Assets
Total assets¥26.2bnat 2022-06-30Cons.Assets
Total assets¥24.6bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥7.4bnat 2022-09-30Cons.Liabilities
Total liabilities¥7.6bnat 2022-06-30Cons.Liabilities
Net assets / equity¥18.8bnat 2022-09-30Cons.Net assets
Net assets / equity¥18.7bnat 2022-06-30Cons.Net assets
Net assets / equity¥16.9bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥8.6bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥9.1bnat 2022-06-30Cons.Cash and deposits
EPS (basic)¥15.292022-07-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥59.552021-07-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥15.292021-07-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio71.8%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio71.1%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio68.8%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-09-30−¥501m
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-09-30−¥501m
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-09-30¥6m
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentrevenue2022-07-01 → 2022-09-30¥4.0bn
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentrevenue external2022-07-01 → 2022-09-30¥3.5bn
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥501m
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentsegment profit2022-07-01 → 2022-09-30¥672m
jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue2022-07-01 → 2022-09-30¥1.9bn
jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue external2022-07-01 → 2022-09-30¥1.9bn
jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segmentsegment profit2022-07-01 → 2022-09-30¥337m
—segment totalrevenue2022-07-01 → 2022-09-30¥5.9bn
—segment totalrevenue external2022-07-01 → 2022-09-30¥5.4bn
—segment totalrevenue intersegment2022-07-01 → 2022-09-30¥501m
—segment totalsegment profit2022-07-01 → 2022-09-30¥1.0bn
Reconciling Itemsreconcilingrevenue2021-07-01 → 2021-09-30−¥498m
Reconciling Itemsreconcilingrevenue intersegment2021-07-01 → 2021-09-30−¥498m
Reconciling Itemsreconcilingsegment profit2021-07-01 → 2021-09-30−¥803,000
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentrevenue2021-07-01 → 2021-09-30¥3.6bn
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentrevenue external2021-07-01 → 2021-09-30¥3.1bn
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥498m
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentsegment profit2021-07-01 → 2021-09-30¥609m
jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue2021-07-01 → 2021-09-30¥1.7bn
jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue external2021-07-01 → 2021-09-30¥1.7bn
jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segmentsegment profit2021-07-01 → 2021-09-30¥262m
—segment totalrevenue2021-07-01 → 2021-09-30¥5.3bn
—segment totalrevenue external2021-07-01 → 2021-09-30¥4.8bn
—segment totalrevenue intersegment2021-07-01 → 2021-09-30¥498m
—segment totalsegment profit2021-07-01 → 2021-09-30¥871m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 353
ItemContextValueUnit
Number of shares held in own name treasury shares etcCurrentQuarterInstant1300
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant1300
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0000
Cash and depositsPrior1YearInstant9123370000JPY
Cash and depositsCurrentQuarterInstant8599899000JPY
Notes and accounts receivable tradePrior1YearInstant3662466000JPY
Notes and accounts receivable tradeCurrentQuarterInstant3984030000JPY
Electronically recorded monetary claims operating caPrior1YearInstant4169136000JPY
Electronically recorded monetary claims operating caCurrentQuarterInstant4135337000JPY
Merchandise and finished goodsPrior1YearInstant1505144000JPY
Merchandise and finished goodsCurrentQuarterInstant1802570000JPY
Work in processPrior1YearInstant400428000JPY
Work in processCurrentQuarterInstant433198000JPY
Raw materials and suppliesPrior1YearInstant384702000JPY
Raw materials and suppliesCurrentQuarterInstant484288000JPY
Other caPrior1YearInstant160572000JPY
Other caCurrentQuarterInstant123079000JPY
Current assetsPrior1YearInstant19405821000JPY
Current assetsCurrentQuarterInstant19562405000JPY
Buildings and structuresPrior1YearInstant4853376000JPY
Buildings and structuresCurrentQuarterInstant4873971000JPY
Accumulated depreciation buildings and structuresPrior1YearInstant-2144793000JPY
Accumulated depreciation buildings and structuresCurrentQuarterInstant-2193512000JPY
Buildings and structures netPrior1YearInstant2708583000JPY
Buildings and structures netCurrentQuarterInstant2680458000JPY
Machinery equipment and vehiclesPrior1YearInstant3714364000JPY
Machinery equipment and vehiclesCurrentQuarterInstant3715511000JPY
Accumulated depreciation machinery equipment and vehiclesPrior1YearInstant-1910485000JPY
Accumulated depreciation machinery equipment and vehiclesCurrentQuarterInstant-2006000000JPY
Machinery equipment and vehicles netPrior1YearInstant1803878000JPY
Machinery equipment and vehicles netCurrentQuarterInstant1709510000JPY
Tools furniture and fixturesPrior1YearInstant1252664000JPY
Tools furniture and fixturesCurrentQuarterInstant1259082000JPY
Accumulated depreciation tools furniture and fixturesPrior1YearInstant-1032481000JPY
Accumulated depreciation tools furniture and fixturesCurrentQuarterInstant-1042939000JPY
Tools furniture and fixtures netPrior1YearInstant220182000JPY
Tools furniture and fixtures netCurrentQuarterInstant216143000JPY
LandPrior1YearInstant1761774000JPY
LandCurrentQuarterInstant1761774000JPY
Construction in progressPrior1YearInstant48723000JPY
Construction in progressCurrentQuarterInstant39232000JPY
Property plant and equipmentPrior1YearInstant6543142000JPY
Property plant and equipmentCurrentQuarterInstant6407118000JPY
Other iaPrior1YearInstant52740000JPY
Other iaCurrentQuarterInstant48492000JPY
Intangible assetsPrior1YearInstant52740000JPY
Intangible assetsCurrentQuarterInstant48492000JPY
Investment securitiesPrior1YearInstant63731000JPY
Investment securitiesCurrentQuarterInstant65508000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-06-30pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-06-30pass
statement vs summary · total assetsconsolidated 2022-09-30pass